0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Adenovirus Diagnostic Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-8K10461
Home | Market Reports | Health| Nursing
Global Adenovirus Diagnostic Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Adenovirus Diagnostic Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8K10461
Report
December 2024
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Adenovirus Diagnostic Testing - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Adenovirus Diagnostic Testing - Market

Adenovirus Diagnostic Testing - Market

The global market for Adenovirus Diagnostic Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Adenovirus Diagnostic Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Adenovirus Diagnostic Testing by region & country, by Type, and by Application.
The Adenovirus Diagnostic Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adenovirus Diagnostic Testing.
Market Segmentation

Scope of Adenovirus Diagnostic Testing - Market Report

Report Metric Details
Report Name Adenovirus Diagnostic Testing - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Danaher, BioMerieux, Ortho Clinical Diagnostics, Roche, SiemensHealthineers, Tosoh, GSKBiologicals, ThermoFisher, Affymetrix, BectonDickinson, BioRad, Cepheid, Diamedix, DiaSorin, Fujirebio, Grifols, Hologic, Lonza, PerkinElmer, Qiagen, Scienion, Sequenom, SeraCare, Wako
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Adenovirus Diagnostic Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Adenovirus Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Adenovirus Diagnostic Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Adenovirus Diagnostic Testing - Market report?

Ans: The main players in the Adenovirus Diagnostic Testing - Market are Abbott, Danaher, BioMerieux, Ortho Clinical Diagnostics, Roche, SiemensHealthineers, Tosoh, GSKBiologicals, ThermoFisher, Affymetrix, BectonDickinson, BioRad, Cepheid, Diamedix, DiaSorin, Fujirebio, Grifols, Hologic, Lonza, PerkinElmer, Qiagen, Scienion, Sequenom, SeraCare, Wako

What are the Application segmentation covered in the Adenovirus Diagnostic Testing - Market report?

Ans: The Applications covered in the Adenovirus Diagnostic Testing - Market report are Hospitals, Specialty Clinics, Diagnostic Centers

What are the Type segmentation covered in the Adenovirus Diagnostic Testing - Market report?

Ans: The Types covered in the Adenovirus Diagnostic Testing - Market report are Imaging Test, Respiratory Measurement, Bloodgas Test, Other

Recommended Reports

Diagnostic Testing

Infectious Disease Detection

Lab and Molecular Diagnostics

1 Market Overview
1.1 Adenovirus Diagnostic Testing Product Introduction
1.2 Global Adenovirus Diagnostic Testing Market Size Forecast
1.3 Adenovirus Diagnostic Testing Market Trends & Drivers
1.3.1 Adenovirus Diagnostic Testing Industry Trends
1.3.2 Adenovirus Diagnostic Testing Market Drivers & Opportunity
1.3.3 Adenovirus Diagnostic Testing Market Challenges
1.3.4 Adenovirus Diagnostic Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Adenovirus Diagnostic Testing Players Revenue Ranking (2023)
2.2 Global Adenovirus Diagnostic Testing Revenue by Company (2019-2024)
2.3 Key Companies Adenovirus Diagnostic Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Adenovirus Diagnostic Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Adenovirus Diagnostic Testing
2.6 Adenovirus Diagnostic Testing Market Competitive Analysis
2.6.1 Adenovirus Diagnostic Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Adenovirus Diagnostic Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenovirus Diagnostic Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Imaging Test
3.1.2 Respiratory Measurement
3.1.3 Bloodgas Test
3.1.4 Other
3.2 Global Adenovirus Diagnostic Testing Sales Value by Type
3.2.1 Global Adenovirus Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Adenovirus Diagnostic Testing Sales Value, by Type (2019-2030)
3.2.3 Global Adenovirus Diagnostic Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Diagnostic Centers
4.2 Global Adenovirus Diagnostic Testing Sales Value by Application
4.2.1 Global Adenovirus Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Adenovirus Diagnostic Testing Sales Value, by Application (2019-2030)
4.2.3 Global Adenovirus Diagnostic Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Adenovirus Diagnostic Testing Sales Value by Region
5.1.1 Global Adenovirus Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Adenovirus Diagnostic Testing Sales Value by Region (2019-2024)
5.1.3 Global Adenovirus Diagnostic Testing Sales Value by Region (2025-2030)
5.1.4 Global Adenovirus Diagnostic Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Adenovirus Diagnostic Testing Sales Value, 2019-2030
5.2.2 North America Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Adenovirus Diagnostic Testing Sales Value, 2019-2030
5.3.2 Europe Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Adenovirus Diagnostic Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Adenovirus Diagnostic Testing Sales Value, 2019-2030
5.5.2 South America Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Adenovirus Diagnostic Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Adenovirus Diagnostic Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Adenovirus Diagnostic Testing Sales Value
6.3 United States
6.3.1 United States Adenovirus Diagnostic Testing Sales Value, 2019-2030
6.3.2 United States Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Adenovirus Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Adenovirus Diagnostic Testing Sales Value, 2019-2030
6.4.2 Europe Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Adenovirus Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Adenovirus Diagnostic Testing Sales Value, 2019-2030
6.5.2 China Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Adenovirus Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Adenovirus Diagnostic Testing Sales Value, 2019-2030
6.6.2 Japan Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Adenovirus Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Adenovirus Diagnostic Testing Sales Value, 2019-2030
6.7.2 South Korea Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Adenovirus Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Adenovirus Diagnostic Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Adenovirus Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Adenovirus Diagnostic Testing Sales Value, 2019-2030
6.9.2 India Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Adenovirus Diagnostic Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Adenovirus Diagnostic Testing Products, Services and Solutions
7.1.4 Abbott Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Recent Developments
7.2 Danaher
7.2.1 Danaher Profile
7.2.2 Danaher Main Business
7.2.3 Danaher Adenovirus Diagnostic Testing Products, Services and Solutions
7.2.4 Danaher Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Danaher Recent Developments
7.3 BioMerieux
7.3.1 BioMerieux Profile
7.3.2 BioMerieux Main Business
7.3.3 BioMerieux Adenovirus Diagnostic Testing Products, Services and Solutions
7.3.4 BioMerieux Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Ortho Clinical Diagnostics Recent Developments
7.4 Ortho Clinical Diagnostics
7.4.1 Ortho Clinical Diagnostics Profile
7.4.2 Ortho Clinical Diagnostics Main Business
7.4.3 Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Products, Services and Solutions
7.4.4 Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Ortho Clinical Diagnostics Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Adenovirus Diagnostic Testing Products, Services and Solutions
7.5.4 Roche Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 SiemensHealthineers
7.6.1 SiemensHealthineers Profile
7.6.2 SiemensHealthineers Main Business
7.6.3 SiemensHealthineers Adenovirus Diagnostic Testing Products, Services and Solutions
7.6.4 SiemensHealthineers Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.6.5 SiemensHealthineers Recent Developments
7.7 Tosoh
7.7.1 Tosoh Profile
7.7.2 Tosoh Main Business
7.7.3 Tosoh Adenovirus Diagnostic Testing Products, Services and Solutions
7.7.4 Tosoh Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Tosoh Recent Developments
7.8 GSKBiologicals
7.8.1 GSKBiologicals Profile
7.8.2 GSKBiologicals Main Business
7.8.3 GSKBiologicals Adenovirus Diagnostic Testing Products, Services and Solutions
7.8.4 GSKBiologicals Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.8.5 GSKBiologicals Recent Developments
7.9 ThermoFisher
7.9.1 ThermoFisher Profile
7.9.2 ThermoFisher Main Business
7.9.3 ThermoFisher Adenovirus Diagnostic Testing Products, Services and Solutions
7.9.4 ThermoFisher Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.9.5 ThermoFisher Recent Developments
7.10 Affymetrix
7.10.1 Affymetrix Profile
7.10.2 Affymetrix Main Business
7.10.3 Affymetrix Adenovirus Diagnostic Testing Products, Services and Solutions
7.10.4 Affymetrix Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Affymetrix Recent Developments
7.11 BectonDickinson
7.11.1 BectonDickinson Profile
7.11.2 BectonDickinson Main Business
7.11.3 BectonDickinson Adenovirus Diagnostic Testing Products, Services and Solutions
7.11.4 BectonDickinson Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.11.5 BectonDickinson Recent Developments
7.12 BioRad
7.12.1 BioRad Profile
7.12.2 BioRad Main Business
7.12.3 BioRad Adenovirus Diagnostic Testing Products, Services and Solutions
7.12.4 BioRad Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.12.5 BioRad Recent Developments
7.13 Cepheid
7.13.1 Cepheid Profile
7.13.2 Cepheid Main Business
7.13.3 Cepheid Adenovirus Diagnostic Testing Products, Services and Solutions
7.13.4 Cepheid Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Cepheid Recent Developments
7.14 Diamedix
7.14.1 Diamedix Profile
7.14.2 Diamedix Main Business
7.14.3 Diamedix Adenovirus Diagnostic Testing Products, Services and Solutions
7.14.4 Diamedix Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.14.5 Diamedix Recent Developments
7.15 DiaSorin
7.15.1 DiaSorin Profile
7.15.2 DiaSorin Main Business
7.15.3 DiaSorin Adenovirus Diagnostic Testing Products, Services and Solutions
7.15.4 DiaSorin Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.15.5 DiaSorin Recent Developments
7.16 Fujirebio
7.16.1 Fujirebio Profile
7.16.2 Fujirebio Main Business
7.16.3 Fujirebio Adenovirus Diagnostic Testing Products, Services and Solutions
7.16.4 Fujirebio Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.16.5 Fujirebio Recent Developments
7.17 Grifols
7.17.1 Grifols Profile
7.17.2 Grifols Main Business
7.17.3 Grifols Adenovirus Diagnostic Testing Products, Services and Solutions
7.17.4 Grifols Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.17.5 Grifols Recent Developments
7.18 Hologic
7.18.1 Hologic Profile
7.18.2 Hologic Main Business
7.18.3 Hologic Adenovirus Diagnostic Testing Products, Services and Solutions
7.18.4 Hologic Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.18.5 Hologic Recent Developments
7.19 Lonza
7.19.1 Lonza Profile
7.19.2 Lonza Main Business
7.19.3 Lonza Adenovirus Diagnostic Testing Products, Services and Solutions
7.19.4 Lonza Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.19.5 Lonza Recent Developments
7.20 PerkinElmer
7.20.1 PerkinElmer Profile
7.20.2 PerkinElmer Main Business
7.20.3 PerkinElmer Adenovirus Diagnostic Testing Products, Services and Solutions
7.20.4 PerkinElmer Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.20.5 PerkinElmer Recent Developments
7.21 Qiagen
7.21.1 Qiagen Profile
7.21.2 Qiagen Main Business
7.21.3 Qiagen Adenovirus Diagnostic Testing Products, Services and Solutions
7.21.4 Qiagen Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.21.5 Qiagen Recent Developments
7.22 Scienion
7.22.1 Scienion Profile
7.22.2 Scienion Main Business
7.22.3 Scienion Adenovirus Diagnostic Testing Products, Services and Solutions
7.22.4 Scienion Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.22.5 Scienion Recent Developments
7.23 Sequenom
7.23.1 Sequenom Profile
7.23.2 Sequenom Main Business
7.23.3 Sequenom Adenovirus Diagnostic Testing Products, Services and Solutions
7.23.4 Sequenom Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.23.5 Sequenom Recent Developments
7.24 SeraCare
7.24.1 SeraCare Profile
7.24.2 SeraCare Main Business
7.24.3 SeraCare Adenovirus Diagnostic Testing Products, Services and Solutions
7.24.4 SeraCare Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.24.5 SeraCare Recent Developments
7.25 Wako
7.25.1 Wako Profile
7.25.2 Wako Main Business
7.25.3 Wako Adenovirus Diagnostic Testing Products, Services and Solutions
7.25.4 Wako Adenovirus Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.25.5 Wako Recent Developments
8 Industry Chain Analysis
8.1 Adenovirus Diagnostic Testing Industrial Chain
8.2 Adenovirus Diagnostic Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Adenovirus Diagnostic Testing Sales Model
8.5.2 Sales Channel
8.5.3 Adenovirus Diagnostic Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Adenovirus Diagnostic Testing Market Trends
    Table 2. Adenovirus Diagnostic Testing Market Drivers & Opportunity
    Table 3. Adenovirus Diagnostic Testing Market Challenges
    Table 4. Adenovirus Diagnostic Testing Market Restraints
    Table 5. Global Adenovirus Diagnostic Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Adenovirus Diagnostic Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Adenovirus Diagnostic Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Adenovirus Diagnostic Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Adenovirus Diagnostic Testing
    Table 10. Global Adenovirus Diagnostic Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenovirus Diagnostic Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Adenovirus Diagnostic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Adenovirus Diagnostic Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Adenovirus Diagnostic Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Adenovirus Diagnostic Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Adenovirus Diagnostic Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Adenovirus Diagnostic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Adenovirus Diagnostic Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Adenovirus Diagnostic Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Adenovirus Diagnostic Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Adenovirus Diagnostic Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Adenovirus Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Adenovirus Diagnostic Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Adenovirus Diagnostic Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Adenovirus Diagnostic Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Adenovirus Diagnostic Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Adenovirus Diagnostic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Adenovirus Diagnostic Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Adenovirus Diagnostic Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Basic Information List
    Table 32. Abbott Description and Business Overview
    Table 33. Abbott Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Abbott (2019-2024)
    Table 35. Abbott Recent Developments
    Table 36. Danaher Basic Information List
    Table 37. Danaher Description and Business Overview
    Table 38. Danaher Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Danaher (2019-2024)
    Table 40. Danaher Recent Developments
    Table 41. BioMerieux Basic Information List
    Table 42. BioMerieux Description and Business Overview
    Table 43. BioMerieux Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of BioMerieux (2019-2024)
    Table 45. BioMerieux Recent Developments
    Table 46. Ortho Clinical Diagnostics Basic Information List
    Table 47. Ortho Clinical Diagnostics Description and Business Overview
    Table 48. Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Ortho Clinical Diagnostics (2019-2024)
    Table 50. Ortho Clinical Diagnostics Recent Developments
    Table 51. Roche Basic Information List
    Table 52. Roche Description and Business Overview
    Table 53. Roche Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Roche (2019-2024)
    Table 55. Roche Recent Developments
    Table 56. SiemensHealthineers Basic Information List
    Table 57. SiemensHealthineers Description and Business Overview
    Table 58. SiemensHealthineers Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of SiemensHealthineers (2019-2024)
    Table 60. SiemensHealthineers Recent Developments
    Table 61. Tosoh Basic Information List
    Table 62. Tosoh Description and Business Overview
    Table 63. Tosoh Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Tosoh (2019-2024)
    Table 65. Tosoh Recent Developments
    Table 66. GSKBiologicals Basic Information List
    Table 67. GSKBiologicals Description and Business Overview
    Table 68. GSKBiologicals Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of GSKBiologicals (2019-2024)
    Table 70. GSKBiologicals Recent Developments
    Table 71. ThermoFisher Basic Information List
    Table 72. ThermoFisher Description and Business Overview
    Table 73. ThermoFisher Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of ThermoFisher (2019-2024)
    Table 75. ThermoFisher Recent Developments
    Table 76. Affymetrix Basic Information List
    Table 77. Affymetrix Description and Business Overview
    Table 78. Affymetrix Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Affymetrix (2019-2024)
    Table 80. Affymetrix Recent Developments
    Table 81. BectonDickinson Basic Information List
    Table 82. BectonDickinson Description and Business Overview
    Table 83. BectonDickinson Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of BectonDickinson (2019-2024)
    Table 85. BectonDickinson Recent Developments
    Table 86. BioRad Basic Information List
    Table 87. BioRad Description and Business Overview
    Table 88. BioRad Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of BioRad (2019-2024)
    Table 90. BioRad Recent Developments
    Table 91. Cepheid Basic Information List
    Table 92. Cepheid Description and Business Overview
    Table 93. Cepheid Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Cepheid (2019-2024)
    Table 95. Cepheid Recent Developments
    Table 96. Diamedix Basic Information List
    Table 97. Diamedix Description and Business Overview
    Table 98. Diamedix Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Diamedix (2019-2024)
    Table 100. Diamedix Recent Developments
    Table 101. DiaSorin Basic Information List
    Table 102. DiaSorin Description and Business Overview
    Table 103. DiaSorin Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of DiaSorin (2019-2024)
    Table 105. DiaSorin Recent Developments
    Table 106. Fujirebio Basic Information List
    Table 107. Fujirebio Description and Business Overview
    Table 108. Fujirebio Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Fujirebio (2019-2024)
    Table 110. Fujirebio Recent Developments
    Table 111. Grifols Basic Information List
    Table 112. Grifols Description and Business Overview
    Table 113. Grifols Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Grifols (2019-2024)
    Table 115. Grifols Recent Developments
    Table 116. Hologic Basic Information List
    Table 117. Hologic Description and Business Overview
    Table 118. Hologic Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Hologic (2019-2024)
    Table 120. Hologic Recent Developments
    Table 121. Lonza Basic Information List
    Table 122. Lonza Description and Business Overview
    Table 123. Lonza Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Lonza (2019-2024)
    Table 125. Lonza Recent Developments
    Table 126. PerkinElmer Basic Information List
    Table 127. PerkinElmer Description and Business Overview
    Table 128. PerkinElmer Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of PerkinElmer (2019-2024)
    Table 130. PerkinElmer Recent Developments
    Table 131. Qiagen Basic Information List
    Table 132. Qiagen Description and Business Overview
    Table 133. Qiagen Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Qiagen (2019-2024)
    Table 135. Qiagen Recent Developments
    Table 136. Scienion Basic Information List
    Table 137. Scienion Description and Business Overview
    Table 138. Scienion Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Scienion (2019-2024)
    Table 140. Scienion Recent Developments
    Table 141. Sequenom Basic Information List
    Table 142. Sequenom Description and Business Overview
    Table 143. Sequenom Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Sequenom (2019-2024)
    Table 145. Sequenom Recent Developments
    Table 146. SeraCare Basic Information List
    Table 147. SeraCare Description and Business Overview
    Table 148. SeraCare Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of SeraCare (2019-2024)
    Table 150. SeraCare Recent Developments
    Table 151. Wako Basic Information List
    Table 152. Wako Description and Business Overview
    Table 153. Wako Adenovirus Diagnostic Testing Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Adenovirus Diagnostic Testing Business of Wako (2019-2024)
    Table 155. Wako Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Adenovirus Diagnostic Testing Downstream Customers
    Table 159. Adenovirus Diagnostic Testing Distributors List
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
    Table 163. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Adenovirus Diagnostic Testing Product Picture
    Figure 2. Global Adenovirus Diagnostic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Adenovirus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Adenovirus Diagnostic Testing Report Years Considered
    Figure 5. Global Adenovirus Diagnostic Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Adenovirus Diagnostic Testing Revenue in 2023
    Figure 7. Adenovirus Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Imaging Test Picture
    Figure 9. Respiratory Measurement Picture
    Figure 10. Bloodgas Test Picture
    Figure 11. Other Picture
    Figure 12. Global Adenovirus Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Adenovirus Diagnostic Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Specialty Clinics
    Figure 16. Product Picture of Diagnostic Centers
    Figure 17. Global Adenovirus Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Adenovirus Diagnostic Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Adenovirus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Adenovirus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Adenovirus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Adenovirus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Adenovirus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Adenovirus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Adenovirus Diagnostic Testing Sales Value (%), (2019-2030)
    Figure 30. United States Adenovirus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Adenovirus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Adenovirus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Adenovirus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Adenovirus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Adenovirus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Adenovirus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Adenovirus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Adenovirus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Adenovirus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Adenovirus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Adenovirus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Adenovirus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Adenovirus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Adenovirus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
    Figure 51. Adenovirus Diagnostic Testing Industrial Chain
    Figure 52. Adenovirus Diagnostic Testing Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Ultrasonics Technologies Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0L6392
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Health Self-monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4V7252
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global High-Acuity Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4O6282
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Marburgvirus Infection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36D6023
Mon Sep 08 00:00:00 UTC 2025

Add to Cart